🔴 HCW Biologics is trading 6% down — reason unconfirmed

HCW Biologics is trading at $1.51, down 5.63%, during the October 12, 2026 session; the reason for the decline remains unconfirmed.

• No company-specific explanation emerged in the search.
• Latest major news: October 9 FDA guidance on IND preparation; filing remains targeted for the first half of 2027, but this does not explain Monday’s drop.
• Broader indexes were nearly flat, while available biotech-industry coverage described recent gains; neither clearly accounts for the move.